Effects of Potentilla fulgens Linn. on carbohydrate and lipid profiles in diabetic mice

Pharmacologyonline

Volumn 2, Issue , 2009, Pages 787-795

  Syiem, D ^a   Khup, P Z ^a   Syiem, A B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Anti hyperlipidemic; Glibenclamide; Glycolytic enzymes; Insulin; Metformin; Potentilla fulgens

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOKINASE; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; PLANT EXTRACT; POTENTILLA FULGENS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPTIMAL DRUG DOSE; PLANT ROOT; POTENTILLA; POTENTILLA FULGENS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 70349156843     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004; 27: 1047-1053.
2. Davis SN, Granner DK. (1996). Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: L.S. Goodman, and A.G Gilman (Eds.). The pharmacological basis of therapeutics. 9th Edition, McGraw Hill, New York 2000; 1487-1517.
3. Rorsman P. Insulin secretion: function and therapy of pancreatic beta-cells in diabetes. Br J Diabetes Vasc Dis 2005; 5: 187-191
4. He Z, King GL. Microvascular complications of diabetes. Endocrin Metab Clin 2004; 33: 215-238.
5. Ginsberg HN. Diabetic dyslipidemia: basic mechanism underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 1996; 4: 27-30.
6. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995; 2: 137-189.
7. Day C. Traditional plant treatments for diabetes mellitus: Pharmaceutical foods. Brit J Nutr 1998; 80: 5-6.
8. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetics potential. J Ethnopharmacol 2002; 81: 81-100.
9. Rafiullah MRM, Siddiqui AW, Mir SR, et al. Antidiabetic activity of some Indian medicinal plants. Pharm Biol 2006; 44: 25-99.
10. Tortosa MCR, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclecrosis. Atherosclerosis 1999; 147: 371-378.
11. Zhang FX, Tan BKH. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J 2000; 41: 1-7.
12. Bavarva JH, Narasimhacharya AVRL. Comparative antidiabetic, hypolipidemic and antioxidant properties of Phyllanthus niruri in normal and diabetic rats. Pharm Biol 2007; 45: 569-574.
13. Lenzen S, Mirzaie-Petri M. Inhibition of glucokinase and hexokinase from pancreatic β-cells and liver by alloxan, alloxantin, dialuric acid and t-butylhydroperoxide. Biomed Res 1991; 12: 297-307.
14. Kessler M, Meier W, Storelli C, Semenza G. The biguanide inhibition of D-glucose transport in membrane vesicles from small intestinal brush borders. Biochem Biophys Acta 1975; 413: 444-452.
15. Pari L, Venkateswaran S. Effect of an aqueous extract of Phaseolus vulgaris on plasma insulin and hepatic key enzymes of glucose metabolism in experimental diabetes. Pharmazie 2003; 58: 916-919.
16. Ng TB, Wong CM, Li WW, Yeung HW. Insulin-like molecules in Momordica charantia seeds. J Ethnopharmacol 1986; 15:107-117.
17. Chattopadhyay RR. Possible mechanism of antihyperglycemic effect of Azardirachta indica leaf extract. J Ethnopharmacol 1999; 67: 373-376.
18. Beck-Nielsen H, Nielsen HO, Pedersen O. Mechanism of action of sulphonylureas with special reference to the extra-pancreatic effect. An overview. Diabetic Med 1988; 5: 613-620.
19. Hoa NK, Norberg A, Sillard R, et al. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets. J Endocrinol 2007; 192: 389-394.
20. Strowski MZ, Li Z, Szalkowski D, et al. Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of Type 2 diabetes. Endocrinology 2004; 145: 5259-5268.
21. Tomczyk M, Latte KP. Potentilla- A review of its phytochemical and pharmacological profile. J Ethnopharmacol 2009; 122: 184-204.
22. Terashima S, Shimizu M, Nakayama H, et al. Studies on aldose reductase inhibitors from medicinal plant of 'sinfito', Potentilla candicans, and further synthesis of their related compounds. Chem Pharm Bull 1990; 38: 2733-2736.
23. Selenina LV, Zozulya RN, Yakovleva TN. Polyphenols of Potentilla Erecta and their biological activity. Rast Resur 1973; 9: 409-414.
24. Syiem D, Syngai G, Khup PZ, Khongwir BS, Kharbuli B. Hypoglycemic effects of Potentilla fulgens L. in normal and alloxan induced diabetic mice. J Ethnopharmacol 2002; 83: 55-61.
25. Syiem D, Syngai C, Kharbuli B, Kayang H, Khongwir BS. Anti-tumor activity of crude extract of Potentilla fulgens. Indian Drugs 2003; 40: 124-125.
26. Harborne JB. Phytochemical Methods, 3rd Edition, Chapman & Hall, London 1998; 4-7.
27. Syiem D, Khup PZ, Syiem AB. Evaluation of anti-diabetic potential of Albizzia lebbek bark in normal and alloxan-induced diabetic mice. Pharmacologyonline 2008; 3: 563-573.
28. Ivorra MD, Paya M, Villar A. Hypoglycemic and insulin release effects of tormentic acid, a new hypoglycemic natural product. Planta Med 1988; 54: 282-286.
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
30. Goward CR, Hartwell R, Atkinson T, Scawen MD. The purification and characterization of glucokinase from the thermophille Bacillus stearothermophilus. Biochem J 1986; 237: 415-420.
31. Baquer NZ, Gupta D. Regulation of metabolic pathways in liver and kidneys during experimental diabetes. Effect of antidiabetic compounds. Indian J Clin Biochem 1998; 13: 62-80.
32. Lenzen S, Tiedge M, Panten U. Glucokinase in pancreatic β-cells and its inhibition by alloxan. Acta Endocrinol 1987; 115: 21-29.
33. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274: 305-315.
34. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetes rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001; 224: 45-51.
35. Wollen N, Bailey CJ. Inhibition of hepatic gluconeogenesis by metformin. Biochem Pharmacol 1988; 37: 4353-4358.
36. Bailey CJ. Biguanides and non insulin dependent diabetes mellitus. Diabetes Care 1992; 15: 755-772.